ProfileGDS4718 / 209983_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 39% 42% 37% 38% 40% 38% 36% 43% 41% 36% 39% 38% 39% 41% 40% 39% 41% 38% 34% 33% 35% 43% 43% 38% 41% 37% 44% 40% 40% 39% 32% 38% 37% 43% 39% 39% 35% 35% 40% 38% 42% 36% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1912144
GSM549102patient 115, normal, homogenized [OPG study]4.953339
GSM549104patient 119, normal, homogenized [OPG study]5.0794442
GSM549108patient 138, normal, homogenized [OPG study]4.9039337
GSM549119patient 077, normal, homogenized [OPG study]4.9258838
GSM549133patient 032, cancer, homogenized [OPG study]4.9338540
GSM549139patient 042, cancer, homogenized [OPG study]4.857438
GSM549099patient 107, normal, homogenized [OPG study]4.8346436
GSM549109patient 139, normal, homogenized [OPG study]5.1618843
GSM549110patient 046, normal, homogenized [OPG study]5.038241
GSM549114patient 063, normal, homogenized [OPG study]4.7525336
GSM549122patient 082, normal, homogenized [OPG study]4.9440939
GSM549134patient 033, cancer, homogenized [OPG study]4.8658338
GSM549136patient 036, cancer, homogenized [OPG study]4.8766739
GSM549140patient 044, cancer, homogenized [OPG study]4.9946241
GSM549111patient 047, normal, homogenized [OPG study]4.9514440
GSM549113patient 057, normal, homogenized [OPG study]4.8746139
GSM549132patient 031, cancer, homogenized [OPG study]5.0432241
GSM549137patient 038, cancer, homogenized [OPG study]4.8752638
GSM549142patient 047, cancer, homogenized [OPG study]4.8477534
GSM549100patient 110, normal, homogenized [OPG study]4.6994133
GSM549107patient 135, normal, homogenized [OPG study]4.731635
GSM549115patient 068, normal, homogenized [OPG study]5.0959943
GSM549116patient 072, normal, homogenized [OPG study]5.1179943
GSM549120patient 078, normal, homogenized [OPG study]4.8929538
GSM549131patient 030, cancer, homogenized [OPG study]4.9629741
GSM549118patient 074, normal, homogenized [OPG study]4.85137
GSM549129patient 027, cancer, homogenized [OPG study]5.2207144
GSM549123patient 088, normal, homogenized [OPG study]4.9605740
GSM549124patient 006, cancer, homogenized [OPG study]5.0400540
GSM549126patient 015, cancer, homogenized [OPG study]4.9605739
GSM549128patient 025, cancer, homogenized [OPG study]4.6065132
GSM549103patient 117, normal, homogenized [OPG study]4.9758738
GSM549117patient 073, normal, homogenized [OPG study]4.8068237
GSM549138patient 041, cancer, homogenized [OPG study]5.1084343
GSM549141patient 045, cancer, homogenized [OPG study]4.905339
GSM549130patient 028, cancer, homogenized [OPG study]4.9302139
GSM549101patient 111, normal, homogenized [OPG study]4.7941135
GSM549105patient 128, normal, homogenized [OPG study]4.7830335
GSM549106patient 134, normal, homogenized [OPG study]4.9695440
GSM549112patient 048, normal, homogenized [OPG study]4.9017238
GSM549125patient 011, cancer, homogenized [OPG study]5.0921342
GSM549127patient 024, cancer, homogenized [OPG study]4.7989136
GSM549135patient 035, cancer, homogenized [OPG study]4.9818941